Login / Signup

Characteristics of pregnant women with diabetes using injectable glucose-lowering drugs in the EVOLVE study.

Elisabeth Reinhardt MathiesenNorsiah AliEleni AnastasiouKatarzyna CyprykHarold W de ValkJorge M DoresFidelma P DunneMagnus EkelundSantiago Durán GarcíaHélène HanaireLise Lotte N HusemoenMarina IvanisevicHans-Peter KempeRikke B NordsborgDavid R McCance
Published in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2021)
Baseline data from this large multinational population of women with pre-existing diabetes indicate that sub-optimal glycemic control, poor pregnancy planning, and chronic concomitant conditions were common in early pregnancy.
Keyphrases
  • glycemic control
  • type diabetes
  • blood glucose
  • pregnant women
  • weight loss
  • insulin resistance
  • pregnancy outcomes
  • cardiovascular disease
  • electronic health record
  • big data
  • drug induced
  • hyaluronic acid